• EAACI 2016: Clinical contraindications to allergen immunotherapy: an EAACI position paper
• WAO 2014 : Recommendations for appropriate sublingual immunotherapy clinical trials
• QUASAR Group : SLIT: indications, follow-up, and management.
• WAO 2014 : Sublingual immunotherapy: World Allergy Organization position paper 2013 update
• ASCIA 2013 Position paper: Jack jumper ant immunotherapy
• EAACI 2012 Position paper: 100 years of allergen immunotherapy & unanswered questions
• EAACI 2012 Position paper: allergen specific immunotherapy in childhood
• EAACI 2011 Task force paper: dose-response relationship in allergen specific immunotherapy
• BSACI 2011: Guidelines: Immunotherapy for allergic rhinitis 
• AAAAI 2010: Allergen immunotherapy: a practice parameter third update (2010)
• WAO 2010: Speaking a Common Language in Grading Subcutaneous Immunotherapy Systemic Reactions: World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System
• WAO 2009: Sublingual Immunotherapy: World Allergy Organization Position Paper 2009.
• WAO 2009: Recommendations for appropriate sublingual immunotherapy clinical trials.
• WAO 2007: Recommendations for Standardization of Clinical Trials with Allergen Specific Immunotherapy for Respiratory Allergy: A Statement of a World Allergy Organization (WAO) Taskforce.
• EAACI 2006: Standards for practical allergen-specific immunotherapy (p. 1-3)
• EAACI 2006: Allergen Products (p. 3-5)
• EAACI 2006: Subcutaneous immunotherapy (p. 5-13)
• EAACI 2006: Noninjective immunotherapy (p. 14-20)
• ASCIA 1997: Specific allergen immunotherapy for asthma